TP53INP1 and non-small cell lung carcinoma: As shown in Fig. 4f–h, transfection with TP53INP1 siRNA effectively decreased TP53INP1 expression in NSCLC cells and abrogated the effect of miR-125b inhibitors on adhesion activity and invasion of NSCLC cells.